Plasma IL-17, IL-35, interferon-γ, SOCS3 and TGF-β levels in pregnant women with preeclampsia, and their relation with severity of disease

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 15, 2014, Pages 1513-1517

  Ozkan, Zehra Sema ^a,c   Simsek, Mehmet ^a   Ilhan, Fulya ^b   Deveci, Derya ^c   Godekmerdan, Ahmet ^b   Sapmaz, Ekrem ^a  

^a Department of Obstetrics and Gynecology ^*  (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c FIRAT UNIVERSITY   (Turkey)

Author keywords

IL 17; IL 35; Inflammation; Preeclampsia; SOCS3

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 35; INTERLEUKIN 4; INTERLEUKIN 6; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, HUMAN; SOCS3 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; APGAR SCORE; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; MATERNAL AGE; MATERNAL PLASMA; PREECLAMPSIA; PROTEIN BLOOD LEVEL; PROTEINURIA; TH1 TH2 BALANCE; BLOOD; CASE CONTROL STUDY; PREGNANCY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKINS; PRE-ECLAMPSIA; PREGNANCY; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84907046511     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.861415     Document Type: Article

References (36)

1. Ahn H, Park J, Gilman-Sachs A, Kwak-Kim J. Immunologic characteristics of preeclampsia, a comprehensive review. Am J Reprod Immunol 2011;65:377-94.
2. Challis JR, Lockwood CJ, Myatt L, et al. Inflammation and pregnancy. Reprod Sci 2009;16:206-15.
3. Sykes L, MacIntyre DA, Yap XJ, et al. The Th1:th2 dichotomy of pregnancy and preterm labour. Mediators Inflamm 2012;2012: 967629.
4. Cemgil Arikan D, Aral M, Coskun A, Ozer A. Plasma IL-4, IL-8, IL-12, interferon-γ and CRP levels in pregnant women with preeclampsia, and their relation with severity of disease and fetal birth weight. J Matern Fetal Neonatal Med 2012;25:1569-73.
5. Toldi G, Rigó Jr J, Stenczer B, et al. Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. Am J Reprod Immunol 2011;66:223-9.
6. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, et al. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol 2012;93: 75-81.
7. Lau SY, Guild SJ, Barrett CJ, et al. Tumor necrosis factoralpha, i{dotless}nterleukin-6, and i{dotless}nterleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. Am J Reprod Immunol. 2013 Jun 24. doi: 10.1111/aji.12138 [Epub ahead of print].
8. Taki A, Abe M, Komaki M, et al. Expression of angiogenesisrelated factors and inflammatory cytokines in placenta and umbilical vessels in pregnancies with preeclampsia and chorioamnionitis/funisitis. Congenit Anom (Kyoto) 2012;52:97-103.
9. Feizollahzadeh S, Taheripanah R, Khani M, et al. Promoter region polymorphisms in the transforming growth factor beta-1 (TGFβ1) gene and serum TGFβ1 concentration in preeclamptic and control Iranian women. J Reprod Immunol 2012;94:216-21.
10. Pinheiro MB, Martins-Filho OA, Mota AP, et al. Severe preeclampsia goes along with a cytokine network disturbance towards a systemic inflammatory state. Cytokine 2013;62:165-73.
11. Wang J, Su L, Zhu T. Effect of dendritic cells on the differentiation of Th1/Th17 in peripheral blood from preeclampsia patients. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2013;29:744-7.
12. Abell K, Watson CJ. The Jak/Stat pathway: a novel way to regulate PI3K activity. Cell Cycle 2005;4:897-900.
13. Carow B, Reuschl AK, Gavier-Widén D, et al. Critical and i{dotless}ndependent role for SOCS3 in either myeloid or T cells in resistance to mycobacterium tuberculosis. PLoS Pathog 2013;9: e1003442.
14. Kupferminc MJ, Peaceman AM, Aderka D, et al. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996;88:420-7.
15. Opsjøn SL, Novick D, Wathen NC, et al. Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnancies. J Reprod Immunol 1995;29:119-34.
16. Wang Y, Lewis DF, Gu Y, et al. Elevated maternal soluble Gp130 and IL-6 levels and reduced Gp130 and SOCS-3 expressions in women complicated with preeclampsia. Hypertension 2011;57: 336-42.
17. Bueno-Sánchez JC, Agudelo-Jaramillo B, Escobar-Aguilerae LF, et al. Cytokine production by non-stimulated peripheral blood NK cells and lymphocytes in early-onset severe pre-eclampsia without HELLP. J Reprod Immunol 2013;97:223-31.
18. Molvarec A, Szarka A, Walentin S, et al. Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia. Clin Chim Acta 2011;412:1957-62.
19. Kronborg CS, Gjedsted J, Vittinghus E, et al. Longitudinal measurement of cytokines in pre-eclamptic and normotensive pregnancies. Acta Obstet Gynecol Scand 2011;90:791-6.
20. Tarnowska-Madra U, Leibschang J, Kowalska B, et al. Levels of immunoreactive cytokines in serum of women with preeclampsia or severe pregnancy hypertension. Ginekol Pol 2010;81:192-6.
21. Boij R, Svensson J, Nilsson-Ekdahl K, et al. Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia. Am J Reprod Immunol 2012;68: 258-70.
22. Bakheit KH, Bayoumi NK, Eltom AM, et al. Cytokines profiles in Sudanese women with preeclampsia. Hypertens Pregnancy 2009; 28:224-9.
23. Mansouri R, Akbari F, Vodjgani M, et al. Serum cytokines profiles in Iranian patients with preeclampsia. Iran J Immunol 2007;4: 179-85.
24. Muralimanoharan S, Maloyan A, Myatt L. Evidence of sexual dimorphism in the placental function with severe preeclampsia. Placenta 2013 Sep 29. pii: S0143-4004(13)00741-8. doi: 10.1016/j.placenta.2013.09.015 [Epub ahead of print].
25. Dhillion P, Wallace K, Herse F, et al. IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am J Physiol Regul Integr Comp Physiol 2012; 303:R353-8.
26. Saito S, Nakashima A, Ito M, Shima T. Clinical implication of recent advances in our understanding of IL-17 and reproductive immunology. Expert Rev Clin Immunol 2011;7:649-57.
27. Martínez-García EA, Chávez-Robles B, Sánchez-Hernández PE, et al. IL-17 increased in the third trimester in healthy women with term labor. Am J Reprod Immunol 2011;65:99-103.
28. Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010;63:601-10.
29. Santner-Nanan B, Peek MJ, Khanam R, et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol 2009;183: 7023-30.
30. Feizollahzadeh S, Taheripanah R, Khani M, et al. Promoter region polymorphisms in the transforming growth factor beta-1 (TGFβ1) gene and serum TGFβ1 concentration in preeclamptic and control Iranian women. J Reprod Immunol 2012;94:216-21.
31. Mao H, Gao W, Ma C, Sun J, et al. Human placental trophoblasts express the immunosuppressive cytokine IL-35. Hum Immunol 2013;74:872-7.
32. Whitehead GS, Wilson RH, Nakano K, et al. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol 2012;129:207-15.
33. Niedbala W, Wei XQ, Cai B, et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007;37:3021-9.
34. Ye S, Wu J, Zhou L, et al. Interleukin-35: the future of hyperimmune-related diseases? J Interferon Cytokine Res 2013; 33:285-91.
35. Zhao S, Gu Y, Dong Q, et al. Altered interleukin-6 receptor, IL-6R and gp130, production and expression and decreased SOCS-3 expression in placentas from women with pre-eclampsia. Placenta 2008;29:1024-8.
36. Dong Q, Fan R, Zhao S, Wang Y. Over-expression of SOCS-3 gene promotes IL-10 production by JEG-3 trophoblast cells. Placenta 2009;30:11-14.